scispace - formally typeset
Open AccessJournal ArticleDOI

TIPS: 25 years later.

Martin Rössle
- 01 Nov 2013 - 
- Vol. 59, Iss: 5, pp 1081-1093
Reads0
Chats0
TLDR
In the 25 years since the first TIPS intervention has been performed, technical standards, indications, and contraindications have been set up and TIPS has gained increasing acceptance in the treatment of the various complications of portal hypertension and vascular diseases of the liver.
About
This article is published in Journal of Hepatology.The article was published on 2013-11-01 and is currently open access. It has received 297 citations till now. The article focuses on the topics: Portal vein thrombosis & Transjugular intrahepatic portosystemic shunt.

read more

Citations
More filters
Journal ArticleDOI

The Transjugular Intrahepatic Portosystemic Shunt: An Update

TL;DR: The best available evidence supports the use of TIPS in secondary prevention of variceal bleeding and in refractory ascites, although TIPS is also commonly used for other indications such as Budd-Chiari syndrome, hepatic hydrothorax, and acutevariceal hemorrhage.
Journal ArticleDOI

Management of portal vein thrombosis in liver cirrhosis

TL;DR: The possibility of spontaneous resolution of partial PVT questions the necessity of anticoagulation for the treatment ofpartial PVT, and a relatively low recanalization rate of complete PVT after antICOagulation therapy suggests its limited usefulness in patients with complete PVt.
Journal ArticleDOI

Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.

TL;DR: It is found muscle wasting, probably owing to reduced processing of ammonia, to be associated with the development of HE after TIPS placement, and nutritional status should be evaluated in patients with sarcopenia before TIPS placed, which might reduce the incidence of HE.
Journal ArticleDOI

Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.

TL;DR: Covered TIPS placement in patients with PVT and moderately decompensated cirrhosis was more effective than EBL combined with propranolol for the prevention of rebleeding, with a higher probability of PVT resolution without increasing the risk of OHE and adverse effects, but this benefit did not translate into improved survival.
References
More filters
Journal ArticleDOI

Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment

TL;DR: The study demonstrates that the incidence of type 2 stenosis of the transjugular shunt can be reduced by combined inhibition of platelet aggregation and PDGF activity.
Journal ArticleDOI

Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.

TL;DR: The clinical outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt (TIPS) for patients with Budd–Chiari syndrome (BCS) is as yet largely unknown.
Journal ArticleDOI

Risk Factors and Prevention of Early Infection After Implantation or Revision of Transjugular Intrahepatic Portosystemic Shunts (Results of a Randomized Study)

TL;DR: A single dose of second-generationcephalosporine or cefotiam does not prevent post interventional infection and strict adherence toaseptic conditions during intervention and early removal of central venous lines may reduce the rate of postinterventional infection considerably.
Journal ArticleDOI

Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment.

TL;DR: Refinements of the parallel stent/stent-graft technique of flow reduction that is adjustable in either direction are described, which resulted in 1-year survival being seen in only the patient who underwent liver transplantation.
Journal ArticleDOI

Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis

TL;DR: PVT in cirrhotic patients may not result from coagulation imbalance, and the levels of pro- and anti-coagulant factors were not statistically different between the PVT and control groups.
Related Papers (5)